Overexpression in LNCaP cells (lowest expressed apelin) or knockdown of apelin in PC3 cells (highest expressed apelin) promoted and reduced prostate cancer cell motility, respectively (Figure 2D–I), suggesting that apelin facilitates prostate cancer migration and invasion. This evidence concerns the gene APLN and prostate carcinoma.